Reaction
Ileectomy reporting signals
As of the last recalculation, Ileectomy appears in 334 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is USTEKINUMAB (PRR 55.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ustekinumab | 72 | 55.6 | 55.7 |
| Vedolizumab | 53 | 45.4 | 45.4 |
| Risankizumab-Rzaa | 28 | 23.2 | 23.2 |